Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.15B | 1.95B | 1.82B | 1.86B | 1.81B |
Gross Profit | 2.00B | 1.73B | 754.10M | 884.30M | 874.30M |
EBITDA | 1.19B | 988.60M | 865.00M | 1.06B | 1.06B |
Net Income | 264.70M | 126.90M | 204.90M | -56.80M | 453.40M |
Balance Sheet | |||||
Total Assets | 16.77B | 15.65B | 14.53B | 14.44B | 14.18B |
Cash, Cash Equivalents and Short-Term Investments | 1.67B | 1.40B | 340.40M | 240.90M | 744.10M |
Total Debt | 10.79B | 10.00B | 8.44B | 7.98B | 8.45B |
Total Liabilities | 14.77B | 13.60B | 12.02B | 11.48B | 11.15B |
Stockholders Equity | 2.00B | 2.06B | 2.51B | 2.96B | 3.03B |
Cash Flow | |||||
Free Cash Flow | -79.90M | -19.00M | 93.50M | 305.90M | 221.80M |
Operating Cash Flow | 918.10M | 745.10M | 787.50M | 934.40M | 865.80M |
Investing Cash Flow | -987.20M | -731.40M | -593.40M | -639.70M | -555.70M |
Financing Cash Flow | 358.80M | 1.04B | -85.00M | -809.70M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $27.46B | 25.64 | 10.43% | 2.33% | 11.79% | 11.69% | |
76 Outperform | $13.71B | 7.48 | 28.57% | 2.71% | 26.64% | 151.43% | |
75 Outperform | $10.50B | 16.81 | 9.78% | 3.50% | 16.41% | 5.65% | |
67 Neutral | $16.46B | 16.85 | 4.47% | 3.80% | 4.76% | 6.06% | |
67 Neutral | $10.16B | 29.75 | 13.03% | 6.20% | 11.73% | ― | |
66 Neutral | $2.71B | 19.97 | 8.67% | 2.64% | 3.83% | -8.75% | |
62 Neutral | $2.88B | 23.05 | 13.95% | 2.49% | 6.79% | 5.96% |